Zentek Ltd. (TSXV:ZEN)
Canada · Delayed Price · Currency is CAD 0.9500
+0.1700 (21.79%)
Jul 31, 2026, 3:59 PM EST
Zentek Financials Overview
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 0.17 | 0.17 | 0.87 | 0.03 | 0.07 | 0.35 |
Revenue Growth | -80.97% | -80.97% | 2826.26% | -59.08% | -79.02% | 14642.38% |
Gross Profit Gross Profit Growth | -1.75 | -1.75 | 0.14 | -0.39 | -0.86 | -0.06 |
Operating Income Operating Income Growth | -10.52 | -10.52 | -9.29 | -12.02 | -14.52 | -31.63 |
Net Income Net Income Growth | -9.77 | -9.77 | -10.04 | -11.7 | -14.41 | -31.69 |
Earnings Per Share EPS Growth | -0.09 | -0.09 | -0.10 | -0.12 | -0.14 | -0.34 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Biotech Biotech Growth | - | - | 0.79 | - |
Intellectual Property Development Intellectual Property Development Growth | 0.17 | 0.17 | 0.08 | 0.03 |
Total Total Growth | 0.17 | 0.17 | 0.87 | 0.03 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1.3 | 1.3 | 0.12 | 3.52 | 10.36 | 26.68 |
Total Debt Total Debt Growth | 1.91 | 1.91 | 0.68 | 1.24 | 1.61 | 2.23 |
Net Cash (Debt) Net Cash Growth | -0.61 | -0.61 | -0.56 | 2.28 | 8.75 | 24.44 |
Net Cash Growth | - | - | - | -73.94% | -64.22% | 809.64% |
Net Cash Per Share Net Cash Per Share Growth | -0.01 | -0.01 | -0.01 | 0.02 | 0.09 | 0.27 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -5.07 | -5.07 | -6.28 | -8.05 | -12.96 | -7.99 |
Capital Expenditures CapEx Growth | -0.7 | -0.7 | -0.18 | -0.59 | -2.27 | -4.3 |
Free Cash Flow Free Cash Flow Growth | -5.77 | -5.77 | -6.47 | -8.64 | -15.23 | -12.29 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | - | - | 16.54% | - | - | -17.61% |
Operating Margin | -6333.65% | -6333.65% | -1064.54% | -40319.97% | -19925.32% | -9110.09% |
Pretax Margin | -5882.61% | -5882.61% | -1150.68% | -39588.72% | -19784.87% | -9128.92% |
Profit Margin | -5882.61% | -5882.61% | -1150.68% | -39254.06% | -19784.87% | -9128.92% |
FCF Margin | -3475.60% | -3475.60% | -741.21% | -28989.62% | -20904.27% | -3540.35% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PS Ratio | 724.42 | 466.32 | 192.48 | 5477.86 | 2828.02 | 1102.00 |